Search
Close this search box.

Redacted is an independent platform, unencumbered by external factors or restrictive policies, on which Clayton and Natali Morris bring you quality information, balanced reporting, constructive debate, and thoughtful narratives.

Canadian public health care will now cover sex reassignment surgery and pharmaceuticals up to $75,000 per person.

The Canada Life Assurance Company, which administers the Public Service Health Care Plan (PSHCP), added “gender-affirming procedures” to its list of coverage starting July 1. The document says that it will provide up to $75,000 to people who are 18 or older, under the care of a physician for gender affirmation, and have exhausted all available coverage offered by the province where they live.

The document also says that the procedures must be considered “medically necessary” by the patients’ doctors. But what is currently considered “gender-affirming” is pharmaceuticals and surgery that create health problems, not solve them. Nor do they cure gender dysphoria by any medical standards. As you can imagine, many Canadians took to the Internet to ask: why is the government paying for this exactly?

Related Articles

Join the mailing list

Get the daily email that makes reading the investment news actually enjoyable.

Related Articles